Pars Plana Vitrectomy- Suprachoroidal Viscopexy for Rhegmatogenous Retinal Detachment Repair.

IF 2.1 2区医学 Q2 OPHTHALMOLOGY

Retina-The Journal of Retinal and Vitreous Diseases Pub Date : 2025-09-05 DOI:10.1097/IAE.0000000000004642

Rajeev H Muni, Isabela Martins Melo, Shiva Sabour, Tomas Minelli, Hatim Batawi, Aurora Pecaku

{"title":"Pars Plana Vitrectomy- Suprachoroidal Viscopexy for Rhegmatogenous Retinal Detachment Repair.","authors":"Rajeev H Muni, Isabela Martins Melo, Shiva Sabour, Tomas Minelli, Hatim Batawi, Aurora Pecaku","doi":"10.1097/IAE.0000000000004642","DOIUrl":null,"url":null,"abstract":"Purpose: To report reattachment rate (RR) of pars plana vitrectomy-suprachoroidal viscopexy (VIT-SCVEXY) for rhegmatogenous retinal detachment (RRD) repair. Additionally, this study compares the anatomic reattachment rate and functional outcomes of VIT-SCVEXY vs pars plana vitrectomy with traditional scleral buckle (PPV-SB) at postoperative month 3 and final follow-up.Methods: A retrospective cohort study conducted at St. Michael's Hospital, Toronto, Canada, between 2023 and 2024. Consecutive cases of RRD with inferior breaks were included, comparing outcomes between those who underwent VIT-SCVEXY (n = 12) vs PPV-SB (n = 12). Cases were matched for age, gender, lens status, retinal detachment characteristics, preoperative visual acuity, and follow-up duration.Results: A suprachoroidal viscoelastic buckle was successfully created under the break(s) in 75.0% (9/12) of PPV-SCVEXY cases. The reattachment rate at 3 months in those with a successful suprachoroidal buckle was 100% (9/9), with a mean LogMAR BCVA of 0.75 ± 0.25 (Snellen 20/100). The reattachment rate for VIT-SCVEXY and PPV-SB cohorts at 3 months was 100% (12/12). At final follow-up, 88.8% (8/9) of patients who had PPV-SCVEXY remained attached, with an overall retinal reattachment rate of 91.6% (11/12) vs 100% (12/12) in the PPV-SB cohort, p=1.0. Mean LogMAR VA was 0.7±0.5 vs 0.7±0.3 (Snellen 20/100), p=0.9. Chemosis was observed in 25.0% (3/12) of VIT-SCVEXY cases, whereas no adverse events were recorded in PPV-SB cases.Conclusions: VIT-SCVEXY may be a less invasive alternative to PPV-SB with comparable anatomic and functional outcomes. However, further investigations are warranted.","PeriodicalId":54486,"journal":{"name":"Retina-The Journal of Retinal and Vitreous Diseases","volume":" ","pages":""},"PeriodicalIF":2.1000,"publicationDate":"2025-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Retina-The Journal of Retinal and Vitreous Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/IAE.0000000000004642","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose: To report reattachment rate (RR) of pars plana vitrectomy-suprachoroidal viscopexy (VIT-SCVEXY) for rhegmatogenous retinal detachment (RRD) repair. Additionally, this study compares the anatomic reattachment rate and functional outcomes of VIT-SCVEXY vs pars plana vitrectomy with traditional scleral buckle (PPV-SB) at postoperative month 3 and final follow-up.

Methods: A retrospective cohort study conducted at St. Michael's Hospital, Toronto, Canada, between 2023 and 2024. Consecutive cases of RRD with inferior breaks were included, comparing outcomes between those who underwent VIT-SCVEXY (n = 12) vs PPV-SB (n = 12). Cases were matched for age, gender, lens status, retinal detachment characteristics, preoperative visual acuity, and follow-up duration.

Results: A suprachoroidal viscoelastic buckle was successfully created under the break(s) in 75.0% (9/12) of PPV-SCVEXY cases. The reattachment rate at 3 months in those with a successful suprachoroidal buckle was 100% (9/9), with a mean LogMAR BCVA of 0.75 ± 0.25 (Snellen 20/100). The reattachment rate for VIT-SCVEXY and PPV-SB cohorts at 3 months was 100% (12/12). At final follow-up, 88.8% (8/9) of patients who had PPV-SCVEXY remained attached, with an overall retinal reattachment rate of 91.6% (11/12) vs 100% (12/12) in the PPV-SB cohort, p=1.0. Mean LogMAR VA was 0.7±0.5 vs 0.7±0.3 (Snellen 20/100), p=0.9. Chemosis was observed in 25.0% (3/12) of VIT-SCVEXY cases, whereas no adverse events were recorded in PPV-SB cases.

Conclusions: VIT-SCVEXY may be a less invasive alternative to PPV-SB with comparable anatomic and functional outcomes. However, further investigations are warranted.

查看原文本刊更多论文

玻璃体切除-脉络膜上粘连术治疗孔源性视网膜脱离。

目的：报道玻璃体平面肌切除术-脉络膜上粘连术（vitv - scvexy）修复孔源性视网膜脱离（RRD）的再附着率（RR）。此外，本研究还比较了viti - scvexy与传统巩膜扣玻璃体切除术（PPV-SB）术后第3个月和最后随访时的解剖再附着率和功能结果。方法：2023年至2024年在加拿大多伦多圣迈克尔医院进行回顾性队列研究。我们纳入了连续的低断裂RRD病例，比较了vitv - scvexy组（n = 12）和PPV-SB组（n = 12）的结果。这些病例根据年龄、性别、晶状体状态、视网膜脱离特征、术前视力和随访时间进行匹配。结果：75.0%（9/12）的PPV-SCVEXY病例在骨折处成功形成脉络膜上粘弹性扣。3个月时，巩膜上扣环成功患者的再附着率为100%(9/9)，平均LogMAR BCVA为0.75±0.25 （Snellen 20/100）。vitv - scvexy和PPV-SB组在3个月时的再附着率为100%（12/12）。在最后的随访中，88.8%（8/9）的PPV-SCVEXY患者仍然附着，总体视网膜再附着率为91.6%(11/12)，而PPV-SB组为100% (12/12),p=1.0。平均LogMAR VA为0.7±0.5 vs 0.7±0.3 (Snellen 20/100), p=0.9。25.0%（3/12）的vitv - scvexy患者出现化学增生，而PPV-SB患者无不良反应。结论：vitv - scvexy可能是PPV-SB的一种侵入性较小的替代方法，具有相似的解剖和功能结果。然而，需要进一步调查。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Retina-The Journal of Retinal and Vitreous Diseases 医学-眼科学

CiteScore

5.70

自引率

9.10%

发文量

554

审稿时长

3-6 weeks

期刊介绍： RETINA® focuses exclusively on the growing specialty of vitreoretinal disorders. The Journal provides current information on diagnostic and therapeutic techniques. Its highly specialized and informative, peer-reviewed articles are easily applicable to clinical practice. In addition to regular reports from clinical and basic science investigators, RETINA® publishes special features including periodic review articles on pertinent topics, special articles dealing with surgical and other therapeutic techniques, and abstract cards. Issues are abundantly illustrated in vivid full color. Published 12 times per year, RETINA® is truly a “must have” publication for anyone connected to this field.